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A B S T R A C T
Progressive expansion of nanomaterials in our everyday life raises concerns about their safety for human health.
Although kidneys are the primary organs of xenobiotic elimination, little attention has been paid to the kidneys
in terms of nanotoxicological studies up to now. Here we investigate the cytotoxic and genotoxic potential of
four solid-core uncoated inorganic nanoparticles (TiO2NPs, SiO2NPs, Fe3O4NPs and AuNPs) using the human
renal proximal tubule epithelial TH1 cells. To mimic the in vivo conditions more realistic, TH1 cells were exposed
in vitro to inorganic NPs under static as well as dynamic conditions for 3 h and 24 h. The medium throughput
alkaline comet assay (12minigels per slide) was employed to evaluate the impact of these NPs on genome
integrity and their capacity to produce oxidative lesions to DNA. The accumulation and localization of studied
inorganic NPs inside the cells was monitored by transmission electron microscopy (TEM) and the efficacy of
internalization of particular NPs was determined by atomic absorption spectroscopy (AAS) and inductively
coupled plasma mass spectrometry (ICP-MS). From all the tested NPs, only Fe3O4NPs induced a slight cyto-
toxicity in TH1 cells exposed to high concentrations (> 700 μg/ml) for 24 h. On the other hand, the inorganic
NPs did not increase significantly the level of DNA strand breaks or oxidative DNA damage regardless of the
treatment mode (static vs. dynamic conditions). Interestingly, substantial differences were observed in the in-
ternalized amount of inorganic NPs in TH1 cells exposed to equivalent (2.2 μg/ml) concentration. Fe3O4NPs
were most efficiently taken up while the lowest quantity of particles was determined in TiO2NPs-treated cells. As
the particle size and shape of individual inorganic NPs in culture medium was nearly identical, it is reasonable to
suppose that the chemical composition may contribute to the differences in the efficacy of NPs uptake.
1. Introduction
The kidneys are vital organs that perform several important phy-
siological functions such as regulation of blood pressure, control of
plasma concentrations of nutrients and electrolytes, reabsorption of
water and small molecules, production of hormones, as well as detox-
ification and excretion of xenobiotics from the body [1,2]. High blood
supply and ability to concentrate toxins, makes the kidneys particularly
susceptible to xenobiotics, including nanoparticles (NPs), which reach
the bloodstream after intentional or unintentional exposure. Generally,
liver and kidneys are the most common accumulation secondary organs
regardless of exposure routes, animal models and physicochemical
properties of NPs [3]. In comparison to lungs, the most important target
organ in the case of occupational exposure [4], the impact of NPs in
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kidneys has though received only little attention. So far, limited number
of in vitro and in vivo studies has proved the capacity of NPs to exert
various adverse effects on kidneys, thus affecting their physiological
functions [5]. Among them, mainly metal NPs and silica, have been
already shown to induce nephrotoxicity and different levels of adverse
renal effects [6–13]. However, up to the date there are no validated or
regulatory approved in vitro models available for predicting ne-
phrotoxicity, which means there is still a great need for the develop-
ment of new in vitro renal cell models.
Renal clearance of waste products and xenobiotics is a multifaceted
process involving glomerular filtration, tubular reabsorption and se-
cretion, and elimination of the compound through urinary excretion,
thus employing all the kidney compartments. Differences in the impact
of NPs on particular nephron structure, the basic structural and func-
tional unit of the kidney, have been detected (reviewed in Du et al.,
2018). For example, signs of glomerulonephritis have been observed in
mice after exposure to 25 nm and 80 nm TiO2NPs [12] as well as
23.5 nm CuNPs [6], both applied by oral gavage. On the other hand, no
significant changes in the glomeruli were found after exposure of mice
to various sizes of AuNPs (10, 20, 50 nm, i.p. exposure) [13]. In contrast
to glomeruli alterations upon NPs exposure, structural changes (renal
fibrosis) and pathological degeneration within the renal proximal
convoluted tubules have been determined in mice exposed to TiO2NPs
and CuNPs [6,12]. These results indicated that the tubular region of the
kidneys might be a preferential site of NPs toxicity. This suggestion
supports the fact that a greater sensitivity of tubular LLC-PK1 cells
compared to mesangial IP15 cells was detected in vitro after treatment
with carbon black nanoparticles and TiO2NPs [14]. Moreover, experi-
ments on rats revealed that even the proximal renal convoluted tubules
are more susceptible to AuNPs toxicity than the distal ones [13].
Therefore, the aim of this study was evaluate the nephrotoxicity of
four inorganic solid-core uncoated NPs using immortalized human
renal proximal tubule epithelial TH1 cell line which displays several
characteristics of the proximal tubule [15]. Tested NPs (titanium di-
oxide/TiO2NPs, silica dioxide/SiO2NPs, magnetite/Fe3O4NPs and gold
nanoparticles/AuNPs) are routinely used in biomedical applications or
consumer products. The proximal tubule epithelial cells are naturally
exposed to fluid shear stress generated by continuously filtrate move-
ment from glomeruli to urinary bladder. In order to more realistically
recapitulate the in vivo conditions, TH1 cells were in vitro exposed to
model inorganic NPs under static as well as dynamic conditions. The
cytotoxicity of selected inorganic NPs was evaluated by alamarBlue®
assay and the alkaline comet assay was used to investigate their impact
on genome integrity and capacity to induce oxidative DNA lesions.
Intracellular localization of NPs and ultrastructural changes in mor-
phology of TH1 cells upon NPs treatment were studied by transmission
electron microscopy (TEM) and the internalized amount of particular
inorganic NPs inside the cells was determined by flame atomic ab-
sorption spectroscopy (FAAS) and inductively coupled plasma mass
spectrometry (ICP-MS).
2. Materials and methods
2.1. Chemicals
Ethidium bromide (EtBr), low-melting-point (LMP) agarose,
normal-melting-point (NMP) agarose, Triton X-100, and HEPES were
purchased from Sigma-Aldrich (Lambda Life, Slovakia), and for-
mamidopyrimidine-DNA glycosylase/AP nuclease (Fpg) was purchased
from New England Biolabs (BioTech, Slovakia). (R)-1-[(10-Chloro-4-
oxo-3-phenyl-4H-benzo(a)quinolizin-1-yl)-carbonyl]-2-pyrrolidine-me-
thanol (Ro 19-8022; RO) was kindly provided by F. Hoffmann –
LaRoche AG (Basel, Switzerland). Culture media, fetal bovine serum
(FBS), antibiotics and other chemicals used for cell cultivation were
purchased from GIBCO (Lambda Life, Slovakia). All other chemicals
and solvents were of analytical grade from commercial suppliers.
2.2. Inorganic nanoparticles (NPs)
All solid-core inorganic NPs (TiO2NPs, SiO2NPs, Fe3O4NPs and
AuNPs) were synthesized and characterized in-depth by group of Prof.
Victor F. Puntes (Institute of Nanoscience and Nanotechnology,
Barcelona, Spain). AuNPs were stabilized by sodium citrate (2.2mM)
while dispersant used for TiO2NPs and Fe3O4NPs was TMAOH (tetra-
methylammonium hydroxide, 10mM). SiO2NPs were kept in Mili-Q
water. All inorganic NPs were stored in the dark and dry place.
2.3. Dynamic light scattering (DLS)
Particle size distribution and colloidal stability of inorganic NPs in
culture medium at 37 °C was determined by DLS using Zetasizer Nano-
ZS (Malvern Instruments, UK) equipped with a 4mW helium/neon laser
(λ=633 nm) and a thermoelectric temperature controller. The mea-
surements were performed at ˜3 min intervals during 1 h at three time
intervals – 0 h (0–1 h), 3 h (3–4 h) and 24 h (23–24 h); every data point
was recorded as the average of at least 11 repetitions. Instrument set-up
was done with respect to the physico-chemical characteristics (ab-
sorption, refractive index, viscosity, temperature) of the studied col-
loidal solutions [16].
2.4. Cell culture
The human renal proximal tubule epithelial TH1 cell line cell line
was obtained from Kerafast Inc. (Boston, USA). The cells were cultured
in DMEM medium with high glucose supplemented with 10% fetal calf
serum (FCS) and antibiotics (penicillin 100 U/ml, streptomycin 100 μg/
ml) on plastic Petri dishes (Ø 100mm) at 37 °C in humidified atmo-
sphere of 5% CO2.
2.5. Treatment of cells
Exponentially growing cells were exposed to different concentra-
tions of inorganic NPs for 3 h and 24 h. All concentrations were pre-
pared freshly before exposure using procedure provided by Prof. Victor
F. Puntes (Institute of Nanoscience and Nanotechnology, Barcelona,
Spain) [17]. Briefly, 1ml of the inorganic NPs was initially mixed with
1ml of FCS and then culture medium with FCS (9ml) was added. From
this basic stock dispersion of NPs in medium, further dilutions were
prepared. The solvents/dispersants (sodium citrate, TMAOH) were also
tested for potential cyto- and genotoxic effects. The treatment of the
cells was ended by removing the medium with inorganic NPs and
washing the cells twice with phosphate-buffered saline (PBS).
2.6. alamarBlue® assay
TH1 cells were seeded into the series of 96 well plates in a density of
2×104/well and cultured in complete culture medium. Exponentially
growing cells were then pre-incubated either in the presence of broad
range of inorganic NPs, solvents/dispersants or untreated (control) cells
for 3 h and 24 h. After treatment, cells were incubated with 100 μl of
working solution of alamarBlue® (Invitrogen, USA) for 4 h according to
the manufacturer’s protocol. The fluorescence (excitation 530 nm,
emission 590 nm) in each well was measured on a microplate reader -
POLARStar OPTIMA- BMG LABTECH.
2.7. Single-cell gel electrophoresis (SCGE, the comet assay)
The capacity of inorganic NPs to induce DNA strand breaks was
analyzed using a medium-throughput format of comet assay (12mini-
gels per slide) according to Shaposhnikov et al. [18] with minor mod-
ifications. Briefly, TH1 cells (1.2× 104) were gently resuspended and
mixed in 1% LMP agarose in PBS (Ca2+ and Mg2+ free); the final
concentration of LMP was 0.75%. Twelve drops of 10 μl (one thousand
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cells per drop) were placed on 1% NMP agarose pre-coated microscopic
slides. After solidification of the gels, the slides were placed in lysis
solution (2.5M NaCl, 100mM Na2EDTA, 10mM Tris-HCl, pH=10 and
1% Triton X-100, at 4 °C) for 1 h to remove cellular proteins. After lysis,
slides were transferred to an electrophoresis box and immersed in an
alkaline solution (300mM NaOH, 1mM Na2EDTA, pH > 13). After
30min of unwinding time, a voltage of 25 V (0.7 V/cm) was applied for
20min at 4 °C. The slides were neutralized with three 5min washes
with Tris–HCl (0.4 M, pH=7.4) and dried with ethanol. Before scoring,
slides were stained with ethidium bromide (EtBr, 5 μg/ml). EtBr-stained
nucleoids were examined with Zeiss Axio Imager.Z2 fluorescence mi-
croscope (Zeiss, Germany) using the computerized image analysis
(Metafer 3.6, MetaSystems GmbH, Altlussheim, Germany). The per-
centage of DNA in the tail (% of tail DNA) was used as a parameter for
DNA damage measurement. One hundred comets were scored per each
sample in each gel.
2.7.1. Oxidative damage to DNA identified by SCGE (Fpg-sensitive sites)
After lysis, slides were washed three times for 5min in endonuclease
buffer (40mM HEPES-KOH, 0.1M KCl, 0.5 mM EDTA, pH 8.0) and then
incubated with formamidopyrimidine-DNA glycosylase/AP nuclease
(Fpg, 0.2 U/slide) for 30min in a humidified atmosphere at 37 °C. The
slides were then transferred to an electrophoresis box and immersed in
an alkaline solution. SCGE was then performed as described above. The
photosensitizer RO 19-8022 was utilized as a positive control in these
experiments. The working concentration (1 μM in PBS) was prepared
freshly before use. The cells were treated with RO 19-8022 in PBS-G
buffer (140mM NaCl, 3 mM KCl, 8mM Na2HPO4, 1mM KH2PO4, 1mM
CaCl2, 0.5 mM MgCl2, 0.1% glucose, pH 7.4) for 2min, and then the
cells were irradiated on ice using a 1000W halogen lamp (Philips
PF811) at a distance of 33 cm for 2min [19].
2.8. Quantification of the internalized amount of inorganic NPs
Flame atomic absorption spectrometry (FAAS) and inductively
coupled plasma mass spectrometry (ICP-MS) were adapted to quantify
the cellular uptake of inorganic NPs. Au and Fe contents in cell samples
were determined by FAAS (AA240FS, Varian, Australia) after sonica-
tion with concentrated nitric acid (Suprapure, Merck, Slovakia). Si and
Ti contents in cells were determined by ICP-MS (XSeries 2, Thermo
Fisher Scientific, Germany) after sonication and high-pressure micro-
wave digestion with concentrated nitric acid and hydrogen peroxide
using standard and collision cell modes, respectively. Sc, Y and In were
chosen as internal standards. The detection limits (LODs) of the in-
struments for Au, Fe, Si, and Ti were 0.010mg/l; 0.008mg/l; 0.40 μg/l;
and 0.046 μg/l, respectively. The limits of quantification (LOQs) of the
instruments for Au, Fe, Si, and Ti were 0.033mg/l; 0.027mg/l; 1.3 μg/
l; and 0.15 μg/l, respectively.
The cellular uptake of NPs expressed as pg of particular element per
cell was finally calculated from the internalized amount of NPs nor-
malized to the total number of treated cells according to the following
formula:
Internalized amount of NPs per cell= internalized amount of NPs/
number of cells
2.9. Transmission electron microscopy (TEM)
The uptake and accumulation of inorganic NPs in TH1 cells was
evaluated by TEM. Cells were plated on Petri dishes (Ø 60mm,
3–5×105 cells/dish) and exposed to inorganic NPs at exponential
phase of growth. After treatment, cells were washed twice with PBS and
trypsinized. TH1 cellular suspension (treated with TiO2NPs, Fe3O4NPs,
AuNPs or untreated) was centrifuged at 1000 rpm for 5min in PBS. The
samples were then fixed with 4% formaldehyde in PBS for 45min. After
post-fixation with 1% osmium tetraoxide (OsO4,) in cacodylate buffer
for 30min, samples were contrasted overnight with a saturated aqueous
solution of uranyl acetate at room temperature. The samples were then
dehydrated in graded ethanol series and propylene oxide, and em-
bedded into Durcupan (Fluka AG, Switzerland). Ultrathin (60 nm)
sections were cut by Power-Tome MT-XL (RMC/Sorvall, Tucson, USA)
ultramicrotome, placed on copper grids covered with formvar mem-
branes and contrasted by lead citrate. The sections were examined with
JEM 1200 electron microscope (Jeol, Tokyo, Japan) at 7500–50000×
magnification. Images were recorded using a Gatan Dual Vission 300W
CCD camera (Gatan Inc., Pleasanton, USA).
2.10. Statistical analysis
Data are given as mean values with ± SD. The differences between
control cells and treated cells were evaluated by Student's t-test and
one-way analysis of variance (ANOVA). The threshold of statistical
significance was set to p < 0.05.
3. Results
3.1. Characteristics of inorganic NPs, particle size distribution and colloidal
stability in culture medium
As physico-chemical properties of NPs are critical to understand
their biological activity, prior to nanotoxicity testing, the character-
ization of concentration, particle size and ζ-potential of tested NPs has
been performed. The basic physico-chemical characteristics of tested
inorganic NPs after preparation are summarized in Table 1. Except
SiO2NPs, the core size of all tested NPs was nearly identical.
The particle size distribution and colloidal stability of particular NPs
in culture medium was measured at three concentrations (Table 2). The
hydrodynamic particle size of each type of NPs increased substantially
in DMEM medium due to agglomeration of particles and absorption of
Table 1
Basic physico-chemical properties of tested inorganic NPs.
Nanoparticles AuNPs SiO2NPs TiO2NPs Fe3O4NPs
inner core diameter [nm] 13.8 ± 1.71 27.6 ± 3.8 5 – 10 7-15
Particle size (DH) diameter
in solvent [nm]
13.8 ± 0.58 (sodium
citrate, 2.2mM)
30.19 ± 10.65 (Mili-Q
water)
23.67 ± 7.93 (tetramethylammonium
hydroxide, 10mM)
19.12 ± 3.91 (tetramethylammonium
hydroxide, 10mM)
PDI 0.219 ± 0.29 0.217 ± 0.01 0.174 ± 0.005 0.437 ± 0.038
Zeta (ξ) potential [mV] −40.9 ± 2.76 −52.1 ± 10.4 −42.0 ± 15.4 −35.9 ± 3.87
Concentration in stock [mg/
ml]
0.066 10.15 5 11.6
Number of particles/ml ˜3.02× 1012 ˜3×1014 ˜5× 1015 ˜5×1015
TEM image
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serum protein(s) on particle surface (protein corona formation).
Fe3O4NPs that manifested polydisperse distribution were colloidally
unstable at 165 and 22 μg/ml concentrations and their aggregation and
sedimentation were visible already after visual inspection. At the lowest
2.2 μg/ml concentration, the colloid dispersion was relatively stable
within the tested time frame. All other types of NPs: AuNPs, TiO2NPs
and SiO2NPs were colloidally stable in culture medium at all three
concentrations used. At the low concentrations (≤ 2.2 μg/ml), DLS
measurements were strongly affected by the presence of small particles
representing the serum proteins (probably BSA) as they are in high
excess in culture medium in comparison to inorganic NPs. In line with
Ji et al. [20], DLS analysis of NPs-free medium (DMEM + 10% FBS +
ATB) confirmed the presence of 6 ± 1 nm particles.
3.2. Cytotoxicity
A broad range of concentrations of particular inorganic NPs was
utilized to evaluate their effect on viability of TH1 cells. In order to
cover as wide concentration range as possible for the cytotoxicity
testing, the highest concentration of particular NP has been calculated
based upon the stock concentration (see Material and Methods), hence
the differences between tested NPs. Concentrations ranging from 0.1 to
3 μg/ml (AuNPs); from 6 to 924 μg/ml (SiO2NPs), from 58 to 1056 μg/
ml (Fe3O4NPs); and from 83 to 454 μg/ml (TiO2NPs) were applied to
TH1 cells for 3 h and 24 h. Under these treatment conditions, none of
the tested inorganic NPs, except Fe3O4NPs at higher concentrations
(> 700 μg/ml), manifested any cytotoxic effects either after 3 h or 24 h
(Fig. 1A–D). No cytotoxic effect was determined after treatment of TH1
cells with the highest concentration of particular solvents/dispersants
after 24 h (data not shown).
3.3. Genotoxicity
Based on the recommendation of EU-funded NaNoReg and
NanoTest projects [21], the concentrations 2.2, 22, and 165 μg/ml
(corresponding to 1, 10 and 75 μg/cm2) were selected for SiO2NPs,
TiO2NPs and Fe3O4NPs. None of these concentrations had any cytotoxic
effect as shown earlier (Fig. 1A–D). In the case of AuNPs, the con-
centrations 0.22, 0.66 and 2.2 μg/ml (corresponding to 0.1, 0.3 and
1 μg/cm2) were used as the concentration of stock solution was sub-
stantially lower. The impact of inorganic NPs on genome stability was
determined by the alkaline comet assay. In order to simulate more
realistic in vivo kidney conditions, TH1 cells were seeded on Transwell
polycarbonate membrane cell culture inserts (3 μm pore density) and
exposed to inorganic NPs under static and dynamic conditions for 3 h
and 24 h. Medium flow rate - 20 μl/min, corresponded in our experi-
mental setup to ˜ 0.2 dyn/cm−2 which reflects the in vivo situation in
kidneys according to Ingber et al. [22]. In addition to DNA breakage,
Table 2
Size distribution of TiO2NPs, SiO2NPs, Fe3O4NPs and AuNPs in culture medium.
TiO2NPs
165 μg/ml 22 μg/ml 2.2 μg/ml
0 h 3 h 24 h 0 h 3 h 24 h 0 h 3 h 24 h
PdI 0.32 ± 0.03 0.32 ± 0.03 0.29 ± 0.01 0.53 ± 0.06 0.46 ± 0.04 0.39 ± 0.06 0.71 ± 0.18 0.42 ± 0.08 0.26 ± 0.01
Z-Ave 251 ± 5 251 ± 5 251 ± 5 204 ± 11 223 ± 4 234 ± 11 161 ± 45 238 ± 10 231 ± 5
Size [nm] (Number) 83 ± 42 72 ± 47 83 ± 45 88 ± 61 91 ± 57 81 ± 53 89 ± 47 80 ± 61 120 ± 38
Size [nm] (Intensity) 367 ± 17 368 ± 26 350 ± 21 357 ± 26 365 ± 29 356 ± 14 357 ± 37 376 ± 22 310 ± 14
Intensity peaks 367 ± 17 368 ± 26 350 ± 21 6 ± 1; 356 ± 24 6 ± 1; 365 ± 29 356 ± 14 6 ± 1; 357 ± 37 376 ± 22 310 ± 14
SiO2NPs
165 μg/ml 22 μg/ml 2.2 μg/ml
0 h 3 h 24 h 0 h 3 h 24 h 0 h 3 h 24 h
PdI 0.56 ± 0.10 0.26 ± 0.01 0.19 ± 0.01 0.53 ± 0.20 0.27 ± 0.02 0.22 ± 0.01 0.55 ± 0.14 0.30 ± 0.06 0.17 ± 0.01
Z-Ave 68 ± 20 130 ± 3 148 ± 2 83 ± 22 132 ± 1 140 ± 2 58 ± 29 124 ± 6 146 ± 2
Size [nm] (Number) 6 ± 1* 87 ± 9 111 ± 6 6 ± 1* 94 ± 8 102 ± 8 6 ± 1* 93 ± 9 110 ± 5
Size [nm] (Intensity) 143 ± 17 174 ± 4 179 ± 4 153 ± 22 178 ± 7 176 ± 4 141 ± 51 174 ± 5 174 ± 4
Intensity peaks 143 ± 17 174 ± 4 179 ± 4 24 ± 4; 153 ± 22 178 ± 7 176 ± 4 141 ± 51 174 ± 5 174 ± 4
Fe3O4NPs
165 μg/ml 22 μg/ml 2.2 μg/ml
0 h 3 h 24 h 0 h 3 h 24 h 0 h 3 h 24 h
PdI 0.40 ± 0.10 0.43 ± 0.08 0.28 ± 0.01 0.61 ± 0.15 0.54 ± 0.08 0.38 ± 0.0.06 0.53 ± 0.15 0.46 ± 0.07 0.28 ± 0.01
Z-Ave 720 ± 27 617 ± 16 355 ± 4 485 ± 70 415 ± 28 180 ± 6 166 ± 63 174 ± 21 145 ± 1
Size [nm] (Number) 495 ± 302 317 ± 188 222 ± 87 20 ± 33 127 ± 89 66 ± 54 7 ± 0.6* 62 ± 30 110 ± 10
Size [nm] (Intensity) 973 ± 281 921 ± 196 488 ± 18 628 ± 61 671 ± 184 275 ± 16 390 ± 112 250 ± 15 197 ± 4
AuNPs
2.2 μg/ml 0.66 μg/ml 0.22 μg/ml
0 h 3 h 24 h 0 h 3 h 24 h 0 h 3 h 24 h
PdI 0.36 ± 0.03 0.67 ± 0.07 0.29 ± 0.01 0.45 ± 0.13 0.62 ± 0.09 0.33 ± 0.01 0.59 ± 0.28 0.40 ± 0.09 0.27 ± 0.01
Z-Ave 17 ± 1 52 ± 15 139 ± 2 18 ± 10 87 ± 12 126 ± 2 56 ± 36 119 ± 8 136 ± 2
Size [nm]
(Number)
6 ± 0.3* 6 ± 1* 124 ± 7 6 ± 1* 6 ± 0.4* 117 ± 8 6 ± 1* 7 ± 1* 111 ± 7
Size [nm]
(Intensity)
26 ± 11 173 ± 26 192 ± 3 23 ± 13 183 ± 10 185 ± 4 127 ± 64 190 ± 3 182 ± 3
Intensity peaks 12 ± 2;
59 ± 14
6 ± 1; 190 ± 4 7 ± 1; 198 ± 4 8 ± 1; 58 ± 11 8 ± 1; 198 ± 3 185 ± 6 7 ± 1; 58 ± 12 7 ± 1;196 ± 6 183 ± 5
* Particles from serum proteins, probably BSA.
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the capacity of inorganic NPs to induce oxidative DNA damage was
assessed as well. None of the inorganic NPs increased significantly the
level of DNA strand breaks and oxidative DNA damage in TH1 cells
compared to control cells when treated under static conditions (Fig. 2A
and B). Similar results were obtained when TH1 cell were treated with
inorganic NPs under dynamic conditions. No significant increase in the
level of DNA strand breaks and oxidative damage to DNA were de-
termined (Fig. 3A and B). Also no changes in basal level of DNA damage
in control TH1 cells were observed upon dynamic exposure
[6.98%±2.36% (3 h) or 10.13%±2.67% (24 h)] when compared to
static conditions 11.63%±3.15% (3 h) or 10.79%±2.97% (24 h).
3.4. Quantification of internalized NPs
For the nanosafety assessment, the quantification of internalized
amount of NPs is critical step and supports the association between the
amount of internalized nanoparticles and their biological effect. In
order to explain the absence of any impact on cell viability and the level
Fig. 1. Cell viability of TH1 cells treated with inorganic NPs.
Fig. 2. The impact of inorganic NPs on genome stability of TH1 cells under
static conditions after 3 h (A) and 24 h (B) of treatment.
Fig. 3. The impact of inorganic NPs on genome stability of TH1 cells under
dynamic conditions after 3 h (A) and 24 h (B) of treatment.
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of DNA damage (strand breaks and oxidative DNA damage), the FAAS
and ICP-MS were employed to rule out the possibility of the failure of
studied NPs to enter the cells. Additionally, to compare the efficacy of
NPs uptake based on their chemical composition, exponentially
growing TH1 cells were exposed to equivalent concentration (2.2 μg/
ml) of the tested inorganic NPs for 24 h. The basal level of particular
elements (Fe, Si, Ti and Au) was determined also in control (untreated)
cells to avoid any false positive results. The Table 3 summarizes the
internalized amount of different elements (expressed as pg of Ti, Si, Fe,
or Au per cell).
As small amounts of Ti, Si and Fe were detected also in control
(untreated) TH1, these quantities were subtracted from the total
amounts of particular elements detected in exposed cells, and the data
presented in the Table 3 represent the net quantity. Taking into the
account the initial amount of NPs that has been used to treat TH1 cell,
the efficacy of the uptake has been calculated and showed that TH1
cells internalized more efficiently Fe3O4NPs and AuNPs compared to
SiO2NPs and TiO2NPs. As the hydrodynamic size of all inorganic NPs in
culture medium was nearly the same (110–120 nm agglomerates) the
effect of chemical composition on NPs uptake cannot be excluded.
Moreover, the core size of inorganic NPs was nearly identical except
SiO2NPs (Table 1).
3.5. The accumulation of NPs in TH1 cells
Following the 24 h treatment with equivalent concentration (2.2 μg/
ml TiO2NPs, Fe3O4NPs and AuNPs), TH1 cells were processed for
electron microscopy to study the impact of inorganic NPs on their ul-
trastructure, preferential accumulation inside the cells and possible
mechanism of internalization. The electron microscopy analysis re-
vealed that all the tested NPs (regardless on the chemical composition)
are present inside the TH1 cells as of vesicles containing NPs were
observed in cytoplasm (Fig. 4A–C). Based on the observation performed
with cells exposed to 165 μg/ml Fe3O4NPs, it is reasonable to predict
that the inorganic NPs are internalized by a process similar to phago-
cytosis that manifested at the active surface of the cell (Fig. 5A–B). The
small aggregates of NPs at the cell surface were surrounded by the
protrusions of plasma membrane and engulfed in vesicles to the cell
(Fig. 5B–D). Phagosomes with NPs interact with lysosomes and form
phagolysosomes. The size of the phagolysosomes and their occurrence
in the cytosol of the cells varied. The occasionally observed fusion of
phagolysosomes (Fig. 5C), may explain the presence of large phagoly-
sosomes filled with accumulated NPs (Fig. 5D). Phagolysosomes con-
tained nanoparticles in dense condensed form together with the grain
matter (Fig. 5A–C). Lipofuscin granules and autophagosomes (Fig. 5D)
were rarely present. These observations indicate that TH1 cells cannot
process excess of NPs, for instance by exocytosis or encapsulation, since
these processes were not observed. An excessive accumulation of NPs
destroys the structure of cells to the extent that prevents their normal
function and, in effect, may lead to cell inactivity, death and formation
of tissue scars.
4. Discussion
Renal clearance of nanoparticles, which have reached the systemic
circulation, is an expected and possible elimination route in living or-
ganisms. For this reason, kidneys might be one of the most important
secondary target organs; and the NPs-induced renal toxicity should be
carefully evaluated.
Several in vitro and in vivo studies have reported that different types
of NPs are able to exert various toxic effects in renal cells/tissue [5],
however the number of such studies is limited. Additionally, because of
the diversity of NPs, especially their physico-chemical properties that
influence their characteristics and behavior, many nano-bio interac-
tions still remain to be understood. Therefore, to provide a compre-
hensive and critical evaluation of the toxicity of NPs on the renal system
further studies are inevitable. The employment of cell culture techni-
ques in (nano)toxicology has gained more importance over the past
decades in order to minimize the experiments on animals. Cowie et al.
[23] studied the suitability of mammalian cells of different origin for
the assessment of genotoxicity of various NPs and the kidney cells used
in their study (HEK293 and COS1) seemed to be one of the most reliable
to detect a dose-response upon NPs treatment. The currently available
and used in vitro human renal cell models such as HK-2 cells and
HEK293 cells (reviewed in [24], this Special Issue), however, lack
sufficient in vivo physiological relevance as the cells are in the majority
of studies cultivated under static conditions as two dimensional (2D)
cultures.
Table 3
The amount of elements (Ti, Si, Fe and Au) detected in TH1 cells exposed to TiO2NPs, SiO2NPs, Fe3O4NPs (2.2 μg/ml, 24 h) and the uptake efficiency in TH1 cells. The
amount of particular element [pg/cell] is expressed as the net value.
Ti [pg/cell] Si [pg/cell] Fe [pg/cell] Au [pg/cell] Cell number [x106] Total applied dose [μg] Internalized amount
Total [μg] [%] from total applied dose
Control cells 0.0018 0.0991 0.0228 0.0 13.20 – – –
TiO2NPs 0.0107 – – – 10.25 33.0 0.128 0.389
SiO2NPs – 0.0430 – – 8.90 33.0 1.265 3.833
Fe3O4NPs – – 1.4672 – 8.83 33.0 13.190 39.970
AuNPs – – – 0.8652 7.42 33.0 6.420 19.455
Fig. 4. Accumulation of NPs in the TH1 cells treated with 2.2 μg/ml TiO2NPs, AuNPs, and Fe3O4NPs for 24h.
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In order to evaluate the impact of selected inorganic NPs under
more realistic in vivo conditions, the human renal TH1 cells were grown
in this study on Transwell membrane inserts and treated with inorganic
NPs under continuous medium flow rate. It has been suggested that
combination of in vitro methods simulating as closely as possible in vivo
conditions should be used to access the possible toxic effects of NPs
[25]. Moreover, culturing TH1 cells on permeable supports also pro-
motes apical-basal polarization that is an important characteristic of
mature epithelial layers, thereby simulating in vivo conditions.
Four inorganic solid-core NPs (TiO2NPs, SiO2NPs, Fe3O4NPs and
AuNPs) that can be found in everyday life commercial products were
evaluated in this study. All inorganic NPs except Fe3O4NPs at higher
concentrations were colloidally stable in culture medium during 24 h,
though the particle size of individual NPs increased substantially
probably due to particle agglomeration and protein corona formation
[26,27]. None of the inorganic NPs induced any DNA strand breaks and
oxidative DNA lesions regardless of the exposure (static and dynamic
conditions). Even with the use of unrealistically high concentrations
(with respect to the common human exposure), no cytotoxicity was
observed, with the exception of Fe3O4NPs (> 700 μg/ml). Despite the
fact that the surface coating of NPs is a widely used procedure to in-
crease the biocompatibility and reduce the potential toxicity, there are
also studies [28] showing no (or low) cytotoxic effect of uncoated in-
organic NPs (etc. Fe3O4NPs) which is in agreement with our findings.
Moreover, our results were in line with L'Azou et al. [14], Halamoda
Kenzaoui et al. [11] and Kermanizadeh et al. [29] who did not detect
any significant increase in ROS formation in human or mammalian
renal cells after exposure to TiO2NPs, Fe3O4NPs and SiO2NPs. On the
other hand, intracellular ROS generation was detected in human renal
HK-2, HEK293 cells and human mesangial IP15 cells [7,30,31], porcine
renal LLC-PK1 cells [32], and rat kidney proximal tubular NRK-52E
cells [33] after exposure to inorganic NPs (AuNPs, TiO2NPs, ZnONPs,
SiO2NPs, CdNPs, AgNPs). Oxidative stress and generation of reactive
oxygen species (ROS) has been proposed as one of the main mechan-
isms underlying NP-induced toxicity [34]. ROS formation may occur
due to NP-mediated damage to the mitochondrial membrane [35] or
NPs may affect the NADPH oxidase in the plasma membrane during
entry into the cell [36]. In the case of iron oxide NPs, it is supposed that
iron ions released from the particle surface due to lysosomal enzymatic
degradation can participate in the Fenton reaction, producing the hy-
droxyl radicals [37]. Treatment of HEK293 cells with Fe2O3NP-condi-
tioned medium revealed that the cytotoxic effect induced by Fe2O3NPs
per se was much higher so the authors concluded that the contribution
of metal ion release to Fe2O3NPs cytotoxicity was fairly low [38].
The glomerular filtration apparatus possesses an effective size cutoff
of 10 nm, in case of metal-based NPs the threshold of 5.5 nm was de-
fined by investigation of the renal clearance of quantum dots of dif-
ferent sizes [39]. In contrast to glomerular filtration membrane, which
acts as a physical barrier (size and charge barrier), the proximal tubules
behave as a chemical barrier for NPs because of their active endocytic
machinery. After glomerular filtration, nanoparticles are concentrated
in the proximal tubules, which can lead to internalization by tubular
cells through endocytosis [40]. However, despite the size cutoff, it has
been shown by Zuckerman et al. [41] that polycationic cyclodextrin
NPs containing siRNA (˜ 70 nm) accumulated in glomerular mesangium
and Williams et al. [42] reported that the “mesoscale” nanoparticles
(PLGA-PEG, 400 nm, i.v. administration) localized selectively in renal
proximal tubules. Also study by Oroojalian et al. [43] showed that
modified-polymyxin-PEI/DNA nanoparticles can effectively target
megalin-expressing kidney cells (megalin being one of the markers for
proximal tubule cells). Taking into consideration the physico-chemical
properties (especially size), all the tested inorganic NPs represent non-
Fig. 5. Electron-microscopic images of ultrastructure TH1 cells exposed to 165 μg/ml Fe3O4NPs for 24 h.
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renal clearable NPs that would be unable to pass glomerular filtration.
However, the full potential to induce any nephrotoxic changes in vivo is
difficult to predict.
Although no cyto- or genotoxic effects were determined in TH1 cells
after 3 h or 24 h treatment, TEM and FAAS analyses clearly demon-
strated that all inorganic NPs tested in this study are internalized as
agglomerates into the cells probably due to extremely dynamic en-
docytic machinery that is the characteristic feature of the renal prox-
imal tubules. Inorganic NPs localized in vesicles surrounded by the
plasma membrane were accumulated in cytoplasm. Occasionally, these
NP-filled vesicles fused with lysosomes creating phagolysosomes. This
phenomenon indicated that TH1 cells cannot process excess of NPs, for
instance by exocytosis or encapsulation as these processes were not
observed. Substantial differences in the internalized amount of parti-
cular inorganic NPs determined in TH1 cells exposed to equivalent
concentration of NPs indicate that the physico-chemical characteristics
affect the efficacy of the uptake. As summarized by Oh and Park [44], it
is believed that the endocytosis efficiency of NPs is strongly dependent
on their properties, such as size, shape, and surface chemistry, as well
as cell type and our previous studies confirmed it as well [45].
In summary, TH1 cells were exposed to inorganic NPs under con-
tinuous medium flow rate to mimic more realistic the in vivo conditions.
Although the inorganic NPs were internalized into TH1 cells, none of
them induced any profound cyto- and genotoxic effects. The comet
assay, also called single cell gel electrophoresis (SCGE), is a sensitive
and rapid technique for quantifying and analyzing DNA damage in
individual cells. This method was adopted for fast screening of genetic
changes to DNA induced by NPs [46]. The medium throughput comet
assay method used in this study allowed not only the acceleration of the
NPs-induced nephrotoxicity screening but additionally minimized the
influence of confounding factor on results as all slides (with and
without restriction enzyme incubation) were processed under the same
experimental conditions.
Conflict of interest
The authors declare that there are no conflicts of interests.
Acknowledgements
The authors would like to thank to Prof. Victor F. Puntes (Institute
of Nanoscience and Nanotechnology, Barcelona, Spain) who kindly
provided inorganic nanoparticles and Ladislav Novota from Institute of
Experimental Endocrinology BMC SAS, Department of Cellular
Cardiology for technical assistance with EM experiments.
This article was created by the realization of the H2020 project
HISENTS No. 685817, COST Action CA15132, VEGA grant 2/0056/17,
project "Center of excellence of environmental health", ITMS No.
26240120033, based on the support of operational Research and de-
velopment program financed from the European Regional Development
Fund; and the EEA projectSK0020. Filip Razga received support within
the SASPRO Programme (Project No. 0057/01/02) co-funded by the
European Union and the Slovak Academy of Sciences.
References
[1] E.A. Lock, C.J. Reed, Xenobiotic metabolizing enzymes of the kidney, Toxicol.
Pathol. 26 (1998) 18–25.
[2] J.W. Lohr, G.R. Willsky, M. a Acara, Renal drug metabolism, Pharmacol. Rev. 50
(1998) 107–141 https://doi.org/10.1177/019262339802600102.
[3] T. Wu, M. Tang, Review of the effects of manufactured nanoparticles on mammalian
target organs, J. Appl. Toxicol. 38 (2018) 25–40, https://doi.org/10.1002/jat.3499.
[4] R. Landsiedel, U.G. Sauer, L. Ma-Hock, J. Schnekenburger, M. Wiemann, Pulmonary
toxicity of nanomaterials: a critical comparison of published in vitro assays and in
vivo inhalation or instillation studies, Nanomedicine 9 (2014) 2557–2585, https://
doi.org/10.2217/nnm.14.149.
[5] I. Iavicoli, L. Fontana, G. Nordberg, The effects of nanoparticles on the renal system,
Crit. Rev. Toxicol. 46 (2016) 490–560, https://doi.org/10.1080/10408444.2016.
1181047.
[6] Z. Chen, H. Meng, G. Xing, C. Chen, Y. Zhao, G. Jia, T. Wang, H. Yuan, C. Ye,
F. Zhao, Z. Chai, C. Zhu, X. Fang, B. Ma, L. Wan, Acute toxicological effects of
copper nanoparticles in vivo, Toxicol. Lett. 163 (2006) 109–120, https://doi.org/
10.1016/j.toxlet.2005.10.003.
[7] F. Wang, F. Gao, M. Lan, H. Yuan, Y. Huang, J. Liu, Oxidative stress contributes to
silica nanoparticle-induced cytotoxicity in human embryonic kidney cells, Toxicol.
In Vitro 23 (2009) 808–815, https://doi.org/10.1016/j.tiv.2009.04.009.
[8] J. Chen, X. Dong, J. Zhao, G. Tang, In vivo acute toxicity of titanium dioxide na-
noparticles to mice after intraperitioneal injection, J. Appl. Toxicol. 29 (2009)
330–337, https://doi.org/10.1002/jat.1414.
[9] Y. Yamagishi, A. Watari, Y. Hayata, X. Li, M. Kondoh, Y. Yoshioka, Y. Tsutsumi,
K. Yagi, Acute and chronic nephrotoxicity of platinum nanoparticles in mice,
Nanoscale Res. Lett. 8 (2013) 1–7, https://doi.org/10.1186/1556-276X-8-395.
[10] C. Ashajyothi, H.K. Handral, C.R. Kelmani, A comparative in vivo scrutiny of bio-
synthesized copper and zinc oxide nanoparticles by Intraperitoneal and intravenous
administration routes in rats, Nanoscale Res. Lett. 13 (2018) 93, https://doi.org/10.
1186/s11671-018-2497-2.
[11] B. Halamoda Kenzaoui, C. Chapuis Bernasconi, L. Juillerat-Jeanneret, Stress reac-
tion of kidney epithelial cells to inorganic solid-core nanoparticles, Cell Biol.
Toxicol. 29 (2013) 39–58, https://doi.org/10.1007/s10565-012-9236-8.
[12] J. Wang, G. Zhou, C. Chen, H. Yu, T. Wang, Y. Ma, G. Jia, Y. Gao, B. Li, J. Sun, Y. Li,
F. Jiao, Y. Zhao, Z. Chai, Acute toxicity and biodistribution of different sized tita-
nium dioxide particles in mice after oral administration, Toxicol. Lett. 168 (2007)
176–185, https://doi.org/10.1016/j.toxlet.2006.12.001.
[13] M.A.K. Abdelhalim, B.M. Jarrar, Renal tissue alterations were size-dependent with
smaller ones induced more effects and related with time exposure of gold nano-
particles, Lipids Health Dis. 10 (2011), https://doi.org/10.1186/1476-511X-10-
163.
[14] B. L’Azou, J. Jorly, D. On, E. Sellier, F. Moisan, J. Fleury-Feith, J. Cambar,
P. Brochard, C. Ohayon-Courtès, In vitro effects of nanoparticles on renal cells, Part.
Fibre Toxicol. 5 (2008) 1–14, https://doi.org/10.1186/1743-8977-5-22.
[15] C.M. Kowolik, S. Liang, Y. Yu, J.-K. Yee, Cre-mediated reversible immortalization of
human renal proximal tubular epithelial cells, Oncogene 23 (2004) 5950–5957,
https://doi.org/10.1038/sj.onc.1207801.
[16] V. Némethová, B. Buliaková, P. Mazancová, A. Bábelová, Š. Michal, D. Morav,
L. Kle, M. Ursínyová, A. Gábelová, F. Rázga, Intracellular uptake of magnetite na-
noparticles: a focus on physico-chemical characterization and interpretation of in
vitro data, Mater. Sci. Eng. C 70 (2017) 161–168, https://doi.org/10.1016/j.msec.
2016.08.064.
[17] G.J. Oostingh, E. Casals, P. Italiani, R. Colognato, R. Stritzinger, J. Ponti, T. Pfaller,
Y. Kohl, D. Ooms, F. Favilli, H. Leppens, D. Lucchesi, F. Rossi, I. Nelissen,
H. Thielecke, V.F. Puntes, A. Duschl, D. Boraschi, Problems and challenges in the
development and validation of human cell-based assays to determine nanoparticle-
induced immunomodulatory effects, Part. Fibre Toxicol. (2011) 1–21.
[18] S. Shaposhnikov, A. Azqueta, S. Henriksson, S. Meier, I. Gaivão, N.H. Huskisson,
A. Smart, G. Brunborg, M. Nilsson, A.R. Collins, Twelve-gel slide format optimised
for comet assay and fluorescent in situ hybridisation, Toxicol. Lett. 195 (2010)
31–34, https://doi.org/10.1016/j.toxlet.2010.02.017.
[19] A. Collins, C. Gedik, N. Vaughan, S. Wood, A. White, J. Dubois, J.F. Rees, S. Loft,
P. Møller, H. Poulsen, J. Cadet, T. Douki, J.L. Ravanat, S. Sauvaigo, H. Faure,
I. Morel, B. Morin, B. Epe, N. Phoa, A. Hartwig, T. Schwerdtle, P. Dolara,
L. Giovannelli, M. Lodovici, R. Olinski, K. Bialkowski, M. Foksinski, D. Gackowski,
Z. Duračková, L. Hlinčiková, P. Korytar, M. Sivonová, M. Dušinská, C. Mislanová,
J. Viña, L. Möller, T. Hofer, J. Nygren, E. Gremaud, K. Herbert, J. Lunec, C. Wild,
L. Hardie, J. Olliver, E. Smith, Measurement of DNA oxidation in human cells by
chromatographic and enzymic methods, Free Radic. Biol. Med. 34 (2003)
1089–1099, https://doi.org/10.1016/S0891-5849(03)00041-8.
[20] Z. Ji, E. Suarez, X. Wang, H. Meng, X. Tian, G. Saji, X. Jin, H. Zhang, E.M.V. Hoek,
H. Godwin, A.E. Nel, Dispersion and stability optimization of TiO2 nanoparticles in
cell culture media, Environ. Sci. Technol. 44 (2014) 7309–7314, https://doi.org/
10.1021/es100417s.Dispersion.
[21] M. Dusinska, N. El Yamani, A.R. Collins, E. Rundén-Pran, L.M. Fjellsbø,
S. Shaposhnikov, S. Zienolddiny, In vitro genotoxicity testing of four reference
metal nanomaterials, titanium dioxide, zinc oxide, cerium oxide and silver: towards
reliable hazard assessment, Mutagenesis 32 (2017) 117–126, https://doi.org/10.
1093/mutage/gew060.
[22] D.E. Ingber, Human kidney proximal tubule on a chip for drug transport and ne-
phrotoxicity assessment, Integr. Biol. (Camb.) 5 (2013) 1089–1198, https://doi.
org/10.1039/c3ib40049b.
[23] H. Cowie, Z. Magdolenova, M. Saunders, M. Drlickova, S. Correia Carreira,
B. Halamoda Kenzaoi, L. Gombau, R. Guadagnini, Y. Lorenzo, L. Walker,
L.M. Fjellsbo, A. Huk, A. Rinna, L. Tran, K. Volkovova, S. Boland, L. Juillerat-
Jeanneret, F. Marano, A.R. Collins, M. Dusinska, Suitability of human and mam-
malian cells of different origin for the assessment of genotoxicity of metal and
polymeric engineered nanoparticles, Nanotoxicology 9 (2015) 57–65, https://doi.
org/10.3109/17435390.2014.940407.
[24] A. Gabelova, K. Kozics, L. Kapka-Skrzypczak, M. Kruszewski, M. Sramkova,
Nephrotoxicity: topical issue, Mut. Res. Gen. Tox. Environ. Mutagen (2018) Special
Issue 2018, accepted.
[25] A.R. Collins, B. Annangi, L. Rubio, R. Marcos, M. Dorn, C. Merker, I. Estrela-Lopis,
M.R. Cimpan, M. Ibrahim, E. Cimpan, M. Ostermann, A. Sauter, N. El Yamani,
S. Shaposhnikov, S. Chevillard, V. Paget, R. Grall, J. Delic, F. Goñi-De-Cerio,
B. Suarez-Merino, V. Fessard, K.N. Hogeveen, L.M. Fjellsbø, E.R. Pran, T. Brzicova,
J. Topinka, M.J. Silva, P.E. Leite, A.R. Ribeiro, J.M. Granjeiro, R. Grafström,
A. Prina-Mello, M. Dusinska, High throughput toxicity screening and intracellular
M. Sramkova, et al. Mutat Res Gen Tox En xxx (xxxx) xxxx
8
detection of nanomaterials, WIREs Nanomed. Nanobiotechnol. 9 (2016), https://
doi.org/10.1002/wnan.1413.
[26] H. Ruh, B. Kühl, G. Brenner-Weiss, C. Hopf, S. Diabaté, C. Weiss, Identification of
serum proteins bound to industrial nanomaterials, Toxicol. Lett. 208 (2012) 41–50,
https://doi.org/10.1016/j.toxlet.2011.09.009.
[27] P. Aggarwal, J.B. Hall, C.B. Mcleland, M.A. Dobrovolskaia, S.E. Mcneil, NIH public
access, Science 61 (2013) 428–437, https://doi.org/10.1016/j.addr.2009.03.009.
Nanoparticle.
[28] Z. Magdolenova, M. Drlickova, K. Henjum, E. Rundén-Pran, J. Tulinska,
D. Bilanicova, G. Pojana, A. Kazimirova, M. Barancokova, M. Kuricova, A. Liskova,
M. Staruchova, F. Ciampor, I. Vavra, Y. Lorenzo, A. Collins, A. Rinna, L. Fjellsbo,
K. Volkovova, A. Marcomini, M. Amiry-Moghaddam, M. Dusinska, Coating-depen-
dent induction of cytotoxicity and genotoxicity of iron oxide nanoparticles,
Nanotoxicology 9 (2015) 44–56, https://doi.org/10.3109/17435390.2013.847505.
[29] A. Kermanizadeh, S. Vranic, S. Boland, K. Moreau, A. Baeza-Squiban, B.K. Gaiser,
L.A. Andrzejczuk, V. Stone, An in vitro assessment of panel of engineered nano-
materials using a human renal cell line: cytotoxicity, pro-inflammatory response,
oxidative stress and genotoxicity, BMC Nephrol. 14 (2013) 96, https://doi.org/10.
1186/1471-2369-14-96.
[30] I. Pujalté, I. Passagne, B. Brouillaud, M. Tréguer, E. Durand, C. Ohayon-Courtès,
B. L’Azou, Cytotoxicity and oxidative stress induced by different metallic nano-
particles on human kidney cells, Part. Fibre Toxicol. 8 (2011) 10, https://doi.org/
10.1186/1743-8977-8-10.
[31] F.A. Ding, Y.P. Li, J. Liu, L. Liu, W.M. Yu, Z. Wang, H.F. Ni, B.C. Liu, P.S. Chen,
Overendocytosis of gold nanoparticles increases autophagy and apoptosis in hy-
poxic human renal proximal tubular cells, Int. J. Nanomed. 9 (2014) 4317–4330,
https://doi.org/10.2147/ijn.s68685.
[32] I. Passagne, M. Morille, M. Rousset, I. Pujalté, B. L’Azou, Implication of oxidative
stress in size-dependent toxicity of silica nanoparticles in kidney cells, Toxicology
299 (2012) 112–124, https://doi.org/10.1016/j.tox.2012.05.010.
[33] X. Valentini, L. Absil, G. Laurent, A. Robbe, S. Laurent, R. Muller, A. Legrand,
D. Nonclercq, Toxicity of TiO2 nanoparticles on the NRK52E renal cell line, Mol.
Cell. Toxicol. 13 (2017) 419–431, https://doi.org/10.1007/s13273-017-0046-1.
[34] A.A. Dayem, M.K. Hossain, S. Bin Lee, K. Kim, S.K. Saha, G.M. Yang, H.Y. Choi,
S.G. Cho, The role of reactive oxygen species (ROS) in the biological activities of
metallic nanoparticles, Int. J. Mol. Sci. 18 (2017) 1–21, https://doi.org/10.3390/
ijms18010120.
[35] R.J. Delfino, C. Sioutas, S. Malik, Potential role of ultrafine particles in associations
between airborne particle mass and cardiovascular health, Environ. Health
Perspect. 113 (2005) 934–946, https://doi.org/10.1289/ehp.7938.
[36] K. Bedard, K.-H. Krause, The NOX family of ROS-Generating NADPH oxidases:
physiology and pathophysiology, Physiol. Rev. 87 (2007) 245–313, https://doi.org/
10.1152/physrev.00044.2005.
[37] M. Valko, C.J. Rhodes, J. Moncol, M. Izakovic, M. Mazur, Free radicals, metals and
antioxidants in oxidative stress-induced cancer, Chem. Biol. Interact. 160 (2006)
1–40, https://doi.org/10.1016/j.cbi.2005.12.009.
[38] P. Dua, K.N. Chaudhari, C.H. Lee, N.K. Chaudhari, S.W. Hong, J.S. Yu, S. Kim,
D.K. Lee, Evaluation of toxicity and gene expression changes triggered by oxide
nanoparticles, Bull. Korean Chem. Soc. 32 (2011) 2051–2057, https://doi.org/10.
5012/bkcs.2011.32.6.2051.
[39] H.S. Choi, W. Liu, P. Misra, E. Tanaka, J.P. Zimmer, B. Itty Ipe, M.G. Bawendi,
J.V. Frangioni, Renal clearance of nanoparticles, Nat. Biotechnol. 25 (2007)
1165–1170, https://doi.org/10.1038/nbt1340.Renal.
[40] B. Du, M. Yu, J. Zheng, Transport and interactions of nanoparticles in the kidneys,
Nat. Rev. Mater. 3 (2018) 358–374, https://doi.org/10.1038/s41578-018-0038-3.
[41] J.E. Zuckerman, A. Gale, P. Wu, R. Ma, M.E. Davis, siRNA delivery to the glo-
merular mesangium using polycationic cyclodextrin nanoparticles containing
siRNA, Nucleic Acid Ther. 25 (2015) 53–64, https://doi.org/10.1089/nat.2014.
0505.
[42] R.M. Williams, J. Shah, H.S. Tian, X. Chen, F. Geissmann, E.A. Jaimes, D.A. Heller,
Selective nanoparticle targeting of the renal tubules, Hypertension 71 (2018)
87–94, https://doi.org/10.1161/HYPERTENSIONAHA.117.09843.
[43] F. Oroojalian, A.H. Rezayan, F. Mehrnejad, A.H. Nia, W.T. Shier, K. Abnous,
M. Ramezani, Efficient megalin targeted delivery to renal proximal tubular cells
mediated by modified-polymyxin B-polyethylenimine based nano-gene-carriers,
Mater. Sci. Eng. C. 79 (2017) 770–782, https://doi.org/10.1016/j.msec.2017.05.
068.
[44] N. Oh, J.H. Park, Endocytosis and exocytosis of nanoparticles in mammalian cells,
Int. J. Nanomed. 9 (2014) 51–63, https://doi.org/10.2147/IJN.S26592.
[45] B. Buliaková, M. Mesárošová, A. Bábelová, M. Šelc, V. Némethová, L. Šebová,
F. Rázga, M. Ursínyová, I. Chalupa, A. Gábelová, Surface-modified magnetite na-
noparticles act as aneugen-like spindle poison, Nanomed. Nanotechnol. Biol. Med.
13 (2017) 69–80, https://doi.org/10.1016/j.nano.2016.08.027.
[46] H.L. Karlsson, S. Di Bucchianico, A.R. Collins, M. Dusinska, Can the comet assay be
used reliably to detect nanoparticle-induced genotoxicity? Environ. Mol. Mutagen.
56 (2015) 82–96, https://doi.org/10.1002/em.21933.
M. Sramkova, et al. Mutat Res Gen Tox En xxx (xxxx) xxxx
9
